资本风云丨锦欣生殖短期资金缺口7亿!“试管婴儿第一股”失色

创业最前线
03 Apr

当年轻人不再执着于婚育,“试管婴儿第一股” 锦欣生殖 增长的速度明显慢了下来。2024年,锦欣生殖实现收益28.12亿元,仅同比微增0.8%。这是自2021年以来,其收入增速首次下滑至个位数。随着二胎、三胎政策的放开,辅助生殖一直被认为是“ 黄金 赛道”。作为这个赛道的龙头企业,锦欣生殖曾吸引了红杉、 中信 银行 等资本的进入,一时风头无两。在三胎政策实施的2021年,其股价一度高达23.798...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10